DALLAS, Texas, June 13, 2023 (SEND2PRESS NEWSWIRE) — Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report. The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit. Sponsored by Rx Savings Solutions, it outlines the complexities of designing […]
Archive | Drugs and Pharmaceuticals
Press Release: PSG Announces Release of Highly Anticipated ‘Trends in Specialty Drug Benefits Report’
By Send2Press Newswire on May 1, 2023 in Business, DALLAS, Texas, Drugs and Pharmaceuticals, Press Releases, Reports and Studies
DALLAS, Texas, May 1, 2023 (SEND2PRESS NEWSWIRE) — Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual ‘Trends in Specialty Drug Benefits report.’ Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research. PSG has been researching and reporting on drug […]
Press Release: NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group (PSG) Announces Artemetrx Extend – Revolutionary Drug Management Reporting Tool Offers Powerful User Insights
By Send2Press Newswire on January 23, 2023 in Business, DALLAS, Texas, Drugs and Pharmaceuticals, Press Releases, Product Launches, Software, Technology
DALLAS, Texas, Jan. 23, 2023 (SEND2PRESS NEWSWIRE) — Artemetrx®, the industry’s most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.
Press Release: Kalyagen Announces Attendance and Speaking Engagement at 8th Annual Biohacking Conference
By Send2Press Newswire on September 13, 2022 in AUSTIN, Texas, Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases
AUSTIN, Texas, Sept. 13, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.
Press Release: Zeteo Biomedical Introduces OrionMRQ™ Nasal Delivery Device for Vaccines
By Send2Press Newswire on May 4, 2022 in Business, Drugs and Pharmaceuticals, Press Releases, Product Launches
PFLUGERVILLE, Texas, May 4, 2022 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo’s latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.
Press Release: Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates is published in the journal Vaccine
By Send2Press Newswire on April 6, 2022 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases
ROCHESTER, Minn., April 6, 2022 (SEND2PRESS NEWSWIRE) — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
Press Release: Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
By Send2Press Newswire on April 6, 2022 in Alliances and Partnerships, Biotechnology, Business, Drugs and Pharmaceuticals, OKLAHOMA CITY, Okla., Press Releases
OKLAHOMA CITY, Okla., AUSTIN, Texas and MELBOURNE, Australia, April 6, 2022 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC’s proprietary offering of MHC peptide targets for oncology with Myrio’s revolutionary Retained Display(tm) (ReD) antibody discovery […]
Press Release: Geminid Systems Unveils Pharmalite CRM to Boost Remote Engagement of Pharma Field Teams
By Send2Press Newswire on December 9, 2021 in Business, Drugs and Pharmaceuticals, Press Releases, Product Launches, REDWOOD CITY, Calif., Software, Technology
REDWOOD CITY, Calif., Dec. 9, 2021 (SEND2PRESS NEWSWIRE) — Geminid Systems, Inc. today announced the global rollout of a SaaS super-app that aims to improve pharmaceutical operations by helping field teams easily overcome challenges arising from the ongoing COVID pandemic.
Press Release: iCell Gene Therapeutics Announces cCAR-T Clinical Publication in the Stem Cell Reviews and Reports Journal
By Send2Press Newswire on September 10, 2021 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Reports and Studies
STONY BROOK, N.Y., Sept. 10, 2021 (SEND2PRESS NEWSWIRE) — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, today announced the publication of their clinical study utilizing cCAR T-cell immunotherapy to successfully treat a patient with lupus.
Press Release: Kalyagen Announces Release of Free eBook on How to Optimize Health Using Stem Cells
By Send2Press Newswire on July 14, 2021 in AUSTIN, Texas, Books and Publishing, Business, Drugs and Pharmaceuticals, Press Releases
AUSTIN, Texas, July 14, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® has announced the release and availability of a free eBook, “The Stemregen Effect – Tapping into the Power of Your Own Stem Cells,” which provides an overview of how stem cells are the body’s repair system and how STEMREGEN®, a natural stem cell enhancer, has been […]